Font Size: a A A

Study On Effect Of Platycodin On Pharmacokinetics Of Difloxacin And Distribution In Lung In Chickens After Oral Administration

Posted on:2008-08-06Degree:MasterType:Thesis
Country:ChinaCandidate:S H WeiFull Text:PDF
GTID:2143360218454400Subject:Basic veterinary science
Abstract/Summary:PDF Full Text Request
Objective: To study the effect of platycodin on pharmacokinetics of difloxacin in chickens and distribution in lung after oral administration. Methods: 195 healthy chickens were allocated into five groups of 39 chickens each at random. The chickens in groupⅠwere orally given with single dose of Difloxacin at 10mg/kg·b·w ,The chickens in groupⅡwere orally given with single dose of Difloxaein at 10mg/kg·b·w and platycodin at 20mg/kg·b·w simultaneously. The chickens in groupⅢwere orally given with single dose of Difloxacin at 10mg/kg·b·w and platycodin at 40mg/kg·b·w simultaneously. The chickens in groupⅣwere orally given with single dose of Difloxacin at 10mg/kg·b·w and platycodin at 60mg/kg·b·w simultaneously. The chickens in groupⅤwere intravenously injected with single dose of Difloxacin at 10mg/kg·b·w. The concentrations of Difloxacin in plasma and lung were determined by reverse phase high performance liquid chromatography with a limit of detection of 0.01 mg/L in plasma and 0.05μg/g in tissues, respectively. The pharmacokinetic variables were calculated by 3P97 PK program and SPSS(11.0) program. Results: The Model were fitted a two-compartment Model with 1st Order Absorption(weight=1).The main pharrnacokinetics parameters and calculated-equations in chickens were as follows, respectively: GroupⅠ: T1/2Ka= (0.037±0.002) h,T1/2α=(0.499±0.051) h, T1/β=(14.429±2.306) h, Tpeak=(0.500±0.278) h, Cmax=(1.834±0.077) mg/L, AUC=(16.294±1.662) (mg/L·h), Ka=(18.506±0.494) (1/h), MRT0→36(h)= (14.228±2.187) h, C=2.256e-1.389t+0.737e-0.048t -2.993e-18.506t。GroupⅡ: T1/2Ka=(0.170±0.034) h,T(1/2α=(2.188±0.929) h, T1/2β=(38.160±3.232) h, T peak=(0.750±0.149) h, Cmax=(0.828±0.040) mg/L, AUC=(19.633±1.512) (mg/L·h), Ka=(4.089±1.226) (1/h), MRT0→36(h)= (17.665±2.079) h, C=0.729e-0.317t+0.321e-0.018t -1.050e-4.089t。GroupⅢ: T1/2Ka=(0.552±0.065) h,T1/2α=(1.389±0.627) h, T1/2β=(36.338±4.895) h, Tpeak=(1.000±0.125) h, C max=(1.010±0.014) mg/L, AUC=(22.874±0.315) (mg/L·h), Ka=(1.256±0.150) (1/h), MRT0→36(h)=(17.314±2.768 )h, C =2.282·e0.499t+0.396·e-0.019t -2.678e-1.25t。GroupⅣ: T1/2Ka=(0.430±0.074) h,T1/2α=(1.646±0.226) h, T1/2β=(71.680±4.214) h, T peak=(1.000±0.041) h, C9max=(1.439±0.016) mg/L, AUC=(32.372±1.579) (mg/L·h), Ka=(1.256±0.205) (1/h) , MRT0→36(h)= (16.2904±2.276) h,C =2.694e-0.421t +0.279e-0.001t -2.973e-1.611t。GroupⅤ: T1/2α=(0.852±0.329) h, T1/21β=(26.367±3.142) h, AUC=(24.704±1.202) (mg/L·h), MRT0→36(h)=(14.435±2.295) h, C =5.124e-πt+2.824e-0.814t+0.533e-0.026t。Conclusions:①Difloxacin in healthy chickens was quickly absorbed with high concentration in plasma, distributed widespread, and eliminated slowly.②Platycodin could influence the pharmacokinetic variables of Difloxacin in healthy chickens significantly: decreased the speed of absorption, but enhanced the degree of absorption; accelerated the distribution from blood to tissues ; retarded the speed of elimination, increased the time of drug action; increased the bioavailability of Difloxacin; Platycodin increased the distribution volume of Difloxacin, manifest that Platycodin make Difloxacin distributed more widespread, furthermore, profit to cure infection of the deep part tissue.③When Platycodin and Difloxacin were orally administered together, the Difloxacin concentration of lung tissue in healthy chickens was increased notably. It was showed that Platycodin is the hylic foundation of the Leading action of platycodon root.
Keywords/Search Tags:Difloxacin, Platycodin, pharmacokinetics, chickens, blood drug level, Leading action, lung drug level
PDF Full Text Request
Related items